157 related articles for article (PubMed ID: 23866362)
81. Mirage or reality?
Prescrire Int; 2013 Jun; 22(139):144. PubMed ID: 23866344
[No Abstract] [Full Text] [Related]
82. [Pharmacogenetics of antineoplastic agents designed for malignant cancers].
Minami H
Nihon Naika Gakkai Zasshi; 2009 Aug; 98(8):1846-53. PubMed ID: 19891101
[No Abstract] [Full Text] [Related]
83. Personalised Medicine, including pharmacogenetics.
Clin Chem Lab Med; 2021 Oct; 59(s1):s820-s864. PubMed ID: 34727632
[No Abstract] [Full Text] [Related]
84. PHARMACOGENETICS.
STEPHAN JC
S Afr Med J; 1964 Jul; 38():525. PubMed ID: 14178549
[No Abstract] [Full Text] [Related]
85. Pharmacogenetics - The Year in Review.
Lupu RA; Wilke RA
S D Med; 2017 Dec; 70(12):533-534. PubMed ID: 29334439
[No Abstract] [Full Text] [Related]
86. Getting Personal: Accelerating Personalised and Precision Medicine Integration into Clinical Cancer Research and Care in Clinical Trials.
Horgan D; Lawler M; Brand A
Public Health Genomics; 2015; 18(6):325-8. PubMed ID: 26565623
[No Abstract] [Full Text] [Related]
87. The Role Of Pharmacogenetics In Individualized Treatment Choices.
Bozina N
Clin Ther; 2016 Oct; 38(10S):e7. PubMed ID: 27673674
[No Abstract] [Full Text] [Related]
88. Pharmacogenetics of epilepsy: one step forward?
Sills GJ
Epilepsy Curr; 2005; 5(6):236-8. PubMed ID: 16372060
[No Abstract] [Full Text] [Related]
89. Pharmacogenetics in medicine: barriers, critical factors and a framework for dialogue.
Zineh I; Lesko LJ
Per Med; 2009 Jul; 6(4):359-361. PubMed ID: 29783536
[No Abstract] [Full Text] [Related]
90. [The DNA, the thread of destiny].
Loriot MA
Rev Med Interne; 2011 Jun; 32(6):337-40. PubMed ID: 21330020
[No Abstract] [Full Text] [Related]
91. Patients with cancer prefer personalised clinical information.
BMJ; 1999 Nov; 319(7219):G. PubMed ID: 10550125
[No Abstract] [Full Text] [Related]
92. Investigating the use of Personalised Medicine in Cancer Trials - an Update.
Hamilton KA; Wilson T
Value Health; 2014 Nov; 17(7):A660. PubMed ID: 27202401
[No Abstract] [Full Text] [Related]
93. Personalised medicine comes a step closer for asthma.
Gottlieb S
BMJ; 2000 Sep; 321(7263):724. PubMed ID: 10999895
[No Abstract] [Full Text] [Related]
94. Pharmacogenetics of hepatitis C therapy.
Liapakis A; Jacobson I
Pharmacogenomics; 2010 Feb; 11(2):135-9. PubMed ID: 20136353
[No Abstract] [Full Text] [Related]
95. Pharmacogenetics tools readily available for those who opt to use them.
Traynor K
Am J Health Syst Pharm; 2018 Jun; 75(12):832-833. PubMed ID: 29880511
[No Abstract] [Full Text] [Related]
96. Pharmacogenetics: The future medicine.
Saini R; Saini S; Sugandha RS
J Adv Pharm Technol Res; 2010 Oct; 1(4):423-4. PubMed ID: 22247884
[No Abstract] [Full Text] [Related]
97. "Pharmacogenetics of Cancer" -
Mini E; Nobili S
Cancer Drug Resist; 2020; 3(2):225-231. PubMed ID: 35582607
[No Abstract] [Full Text] [Related]
98. Pharmacogenetics and personalised medicine: maintain a critical approach.
Prescrire Int; 2013 Jun; 22(139):161-3. PubMed ID: 23866362
[TBL] [Abstract][Full Text] [Related]
99. Pharmacogenetic application in personalized cancer treatment.
Kristyanto H; Utomo AR
Acta Med Indones; 2010 Apr; 42(2):109-15. PubMed ID: 20513938
[TBL] [Abstract][Full Text] [Related]
100. Availability of pharmacogenetic and pharmacogenomic information in anticancer drug monographs in France: personalized cancer therapy.
Albertini L; Siest G; Jeannesson E; Visvikis-Siest S
Pharmacogenomics; 2011 May; 12(5):681-91. PubMed ID: 21619430
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
